Clinical trial
Assessment of Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
- Lead sponsor
- Guerbet
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 25, 2013
- Completion date
- April 17, 2015
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain lesion, healthy volunteers